Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-22-112138
Filing Date
2022-04-21
Accepted
2022-04-21 08:00:30
Documents
5
Period of Report
2022-06-01

Document Format Files

Seq Description Document Type Size
1 DEF 14A d157715ddef14a.htm DEF 14A 352833
2 GRAPHIC g157715g00k03.jpg GRAPHIC 24659
3 GRAPHIC g157715g00s02.jpg GRAPHIC 141455
4 GRAPHIC g157715g00s03.jpg GRAPHIC 120362
5 GRAPHIC g157715g78x09.jpg GRAPHIC 37122
  Complete submission text file 0001193125-22-112138.txt   787347
Mailing Address 830 WINTER STREET WALTHAM MA 02451
Business Address 830 WINTER STREET WALTHAM MA 02451 857-399-9500
TScan Therapeutics, Inc. (Filer) CIK: 0001783328 (see all company filings)

EIN.: 825282075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40603 | Film No.: 22839700
SIC: 2836 Biological Products, (No Diagnostic Substances)